Ahmad Salehi, M.D., Ph.D.
Ahmad Salehi, M.D., Ph.D.
Adjunct Professor, Stanford University, Adjunct Professor Pepperdine University
Підтверджена електронна адреса в stanford.edu - Домашня сторінка
Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients
FW Van Leeuwen, DPV de Kleijn, HH van den Hurk, A Neubauer, ...
Science 279 (5348), 242, 1998
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration
A Salehi, JD Delcroix, PV Belichenko, K Zhan, C Wu, JS Valletta, ...
Neuron 51 (1), 29-42, 2006
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion
JD Cooper, A Salehi, JD Delcroix, CL Howe, PV Belichenko, ...
Proceedings of the National Academy of Sciences 98 (18), 10439, 2001
Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome
PV Belichenko, E Masliah, AM Kleschevnikov, AJ Villar, CJ Epstein, ...
The Journal of Comparative Neurology 480 (3), 281-298, 2004
Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling
C Phillips, MA Baktir, M Srivatsan, A Salehi
Front Cell Neurosci 8 (170), 47, 2014
Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype‐phenotype relationships
PV Belichenko, AM Kleschevnikov, A Salehi, CJ Epstein, WC Mobley
The Journal of comparative neurology 504 (4), 329-345, 2007
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease
S Peng, DJ Garzon, M Marchese, W Klein, SD Ginsberg, BM Francis, ...
The Journal of Neuroscience 29 (29), 9321, 2009
The “Down syndrome critical region” is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome
NP Belichenko, PV Belichenko, AM Kleschevnikov, A Salehi, RH Reeves, ...
The Journal of Neuroscience 29 (18), 5938-5948, 2009
Ascending monoaminergic systems alterations in Alzheimer's disease; Translating basic science into clinical care.
SA Trillo L, Das D, Hsieh W, Medina B, Moghadam S
Neurosci Biobehav Rev, 144-149, 2013
Neuropathological hallmarks of Alzheimer's and Parkinson's diseases
H Braak, RAI de Vos, ENH Jansen, H Bratzke, E Braak
Progress in brain research 117, 267-285, 1998
Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease
A Salehi, J Verhaagen, PA Dijkhuizen, DF Swaab
Neuroscience 75 (2), 373-387, 1996
Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome
A Salehi, M Faizi, D Colas, J Valletta, J Laguna, R Takimoto-Kimura, ...
Science Translational Medicine 1 (7), 7ra17-7ra17, 2009
Traffic at the intersection of neurotrophic factor signaling and neurodegeneration
A Salehi, JD Delcroix, WC Mobley
Trends in neurosciences 26 (2), 73-80, 2003
Alzheimer’s disease and NGF signaling
A Salehi, JD Delcroix, DF Swaab
Journal of neural transmission 111 (3), 323-345, 2004
Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis
SJ Tamaki, Y Jacobs, M Dohse, A Capela, JD Cooper, M Reitsma, D He, ...
Cell stem cell 5 (3), 310-319, 2009
Excitatory‐inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome
PV Belichenko, AM Kleschevnikov, E Masliah, C Wu, R Takimoto‐Kimura, ...
The Journal of Comparative Neurology 512 (4), 453-466, 2009
Cells in human postmortem brain tissue slices remain alive for several weeks in culture
The FASEB journal 16 (1), 54-60, 2002
Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus
A Salehi, PJ Lucassen, CW Pool, NK Gonatas, R Ravid, DF Swaab
Neuroscience 59 (4), 871-880, 1994
Increased efficiency of the GABAA and GABAB receptor–mediated neurotransmission in the Ts65Dn mouse model of Down syndrome
AM Kleschevnikov, PV Belichenko, J Gall, L George, R Nosheny, ...
Neurobiology of Disease, 2011
The Role of NMDA Receptors in the Pathophysiology and Treatment of Mood Disorders.
SA Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D
Neurosci Biobehav Rev. 14, 2014
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20